Tag: Tb

World-health-Organisation1
TB remains world's deadliest infectious disease: WHO

Geneva: Tuberculosis (TB) remains the world’s deadliest infectious disease although global efforts have averted an estimated 54 million tuberculosis (TB) deaths since 2000, the World Health Organization (WHO) warned on Tuesday. WHO, in its latest 2018 Global TB Report, says countries are still not doing enough to end TB by 2030 and calls for an […]

  • Thursday, 08 July 2021
youth-alcohol
Alcohol may increase death risk in young TB patients

New York: Increased consumption of alcohol in people with tuberculosis (TB) may accelerate their risk of death, scientists led by an Indian-origin researcher have found. Chronic alcohol consumption modulates a host of immune defense mechanisms and increases susceptibility to infections with various pathogens such as Mycobacterium tuberculosis (Mtb) — the TB-causing bacterium. In the study, […]

  • Thursday, 08 July 2021
blood test
New blood test to predict TB onset two years in advance

Johannesburg: Researchers have developed a new blood test that can more accurately predict the development of tuberculosis (TB) up to two years before its onset in high-risk patients. The new test predicts TB particularly in people living with persons having active TB — a condition when the immune system is unable to stop the bacteria […]

  • Wednesday, 07 July 2021
Citizens, organisations should take the lead to end TB: Modi

New Delhi: On World Tuberculosis (TB) Day, Prime Minister Narendra Modi on Saturday urged citizens and organisations to take the lead to end the disease. “In the spirit of this year’s World TB Day theme of ‘Wanted: Leaders for a TB-free world’, I urge citizens and organisations to take the lead in the movement to […]

  • Wednesday, 07 July 2021
narendra-modi
PM sets 2025 deadline for TB-Free India

New Delhi: Prime Minister Narendra Modi on Tuesday set deadline of 2025 to free India from tuberculosis (TB), five years ahead of the global deadline set by World Health Organisation (WHO). “The deadline to eradicate TB from the world has been set at 2030. But I declare that India would be free from tuberculosis five years […]

  • Wednesday, 07 July 2021
New substance may help combat tuberculosis

London: Researchers have discovered a substance that may help combat the bacterium that causes life-threatening tuberculosis (TB) infections. The substance, called beta lactone EZ120, interferes with the formation of the bacterium’s mycomembrane. As this membrane is known to hamper the effect of many medications, this new substance offers hope of fighting the bacteria that can […]

  • Tuesday, 06 July 2021
Adopt tailored solutions to eliminate TB by 2030: WHO

New Delhi: The World Health Organisation (WHO) has told the South East Asian countries to integrate their national plans and mobilise and utilise resources efficiently to reach the Tuberculosis elimination target of 2030, a statement said on Sunday. The WHO South East Asia Region includes India, Bangladesh, Bhutan, North Korea, Indonesia, Maldives, Myanmar, Nepal, Sri […]

  • Tuesday, 06 July 2021
Improved diagnostics for TB under development in India: Expert

Kolkata: India needs advanced diagnostics to combat tuberculosis (TB) early and accurately in the wake of drug resistance, an expert said, adding that several such systems are under development. The need of the hour is point-of-care tests (POCT) which essentially brings the tests to the suspected person, increasing the likelihood of faster detection and quick […]

  • Tuesday, 22 June 2021
TB-patients
Researchers identify molecule effective in killing tuberculosis bacteria

Pretoria: Researchers have found a molecule that is effective against tuberculosis, says a new study on mice. In the study, the group describes how it worked when tested in vitro and in a mouse model. Tuberculosis is a bacterial infection caused by Mycobacterium tuberculosis (Mtb). This airborne pathogen tends to infect the lungs and is […]

  • Tuesday, 04 May 2021
drug
New TB drug may shorten treatment duration: Study

New York: A new experimental antibiotic for tuberculosis (TB) has been shown to be more effective against TB than Isoniazid, a decades old drug which is currently one of the standard treatment for the disease, finds a study on mice. The new drug, called AN12855, has several advantages over Isoniazid as Isoniazid requires conversion to […]

  • Tuesday, 04 May 2021
HIV-TB
India cut 84% TB deaths in AIDS patients by 2017

Geneva: India achieved 84 per cent reduction in tuberculosis deaths among people living with HIV by 2017 – three years ahead of the target, said a report by The Joint United Nations Programme on HIV/AIDS (UNAIDS). The report on Friday showed that India is among the five low or middle-income countries — Eritrea (83 per […]

  • Monday, 03 May 2021
Anti-TB
Anti-TB drugs may not prevent reinfection

Toronto: Anti-tuberculosis (TB) drugs cause changes to gut microbiota and increase susceptibility to Mycobacterium tuberculosis (Mtb) — a major reason why current treatments are ineffective in preventing reinfections, say researchers. The study showed that chronic use of antibiotics controls TB infection but also leads to disruption of gut microbiota. This, in turn, leads to the […]

  • Monday, 03 May 2021
asprin
Aspirin can aid in fight against tuberculosis: Study

Sydney: Aspirin can prevent the tuberculosis (TB) bacterium from hijacking immune cells and allow the body to control infection better, say researchers who found that the common pain killer could treat the top infectious killer worldwide that claims around 4,400 lives a day. Researchers from the Centenary Institute in Sydney found that the TB bacterium […]

  • Sunday, 02 May 2021
Asthma
Asthma patients skipping doses owing to high cost: Study

Sydney: Out-of-pocket costs are preventing many people from taking vital asthma medication, says a new study, calling for urgent interventions to promote discussions between patients and doctors about the cost of medicines to treat asthma. The most commonly prescribed preventer treatments for asthma contain inhaled corticosteroids (ICS) which, if taken regularly, reduce the severity of […]

  • Thursday, 29 April 2021
TB-patients
TB survivors at higher risk of developing lung damage

New Delhi: Tuberculosis (TB) survivors, especially those living in India, are at a higher risk of developing lasting damage to lungs, according to a study done on more than 2,000 Indian patients. Published in the Lancet Global Health, the study has found that more than one-third of patients who are successfully cured of TB with […]

  • Tuesday, 27 April 2021
scrollToTop